# Palo Alto Investors LP 13F holdings Q2 2026: $724 million

Palo Alto Investors LP reported $724 million in 13F securities across 52 positions for the quarter ended June 30, 2026, in a holdings report filed August 19, 2026. Its largest holding was PTC Therapeutics Inc at $75 million, 10.4% of the reported value. Since Q1 2026 it opened 3 new positions and exited 2.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $723,718,198
- Positions: 52
- Filed: August 19, 2026
- Report type: 13F holdings report
- CIK: 1306923
- Form 13F file number: 028-11013
- CRD number: 109171
- Business address: 101 University Ave Suite 200, Palo Alto, CA 94301
- SEC filing: [0002073679-26-000102](https://www.sec.gov/Archives/edgar/data/1306923/000207367926000102/0002073679-26-000102-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/palo-alto-investors-lp-109171)

## Top 25 holdings by value

The largest of 52 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [PTC Therapeutics Inc](https://specstream.ai/data/institutional-holders/ptc-therapeutics-inc-69366j200) | COM | 918,846 | $75 million | -2,761 |
| [Acadia Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/acadia-pharmaceuticals-inc-004225108) | COM | 2,864,096 | $72.5 million | -8,599 |
| [Insmed Inc](https://specstream.ai/data/institutional-holders/insmed-inc-457669307) | COM PAR $.01 | 413,980 | $44.1 million | -1,289 |
| [Mirum Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/mirum-pharmaceuticals-inc-604749101) | COM | 348,808 | $40.8 million | +23,633 |
| [Anaptysbio Inc](https://specstream.ai/data/institutional-holders/anaptysbio-inc-032724106) | COM | 603,489 | $40.7 million | -34,672 |
| [Biomarin Pharmaceutical Inc](https://specstream.ai/data/institutional-holders/biomarin-pharmaceutical-inc-09061g101) | COM | 682,777 | $39.1 million | -2,405 |
| [Dyne Therapeutics Inc](https://specstream.ai/data/institutional-holders/dyne-therapeutics-inc-26818m108) | COM | 1,647,521 | $36.6 million | -5,451 |
| [United Therapeutics Corp Del](https://specstream.ai/data/institutional-holders/united-therapeutics-corp-del-91307c102) | COM | 62,587 | $33.9 million | -222 |
| [Disc Medicine Inc](https://specstream.ai/data/institutional-holders/disc-medicine-inc-254604101) | COM | 416,646 | $30.5 million | +14,927 |
| [Biogen Inc](https://specstream.ai/data/institutional-holders/biogen-inc-09062x103) | COM | 140,279 | $30.3 million | -440 |
| [Iovance Biotherapeutics Inc](https://specstream.ai/data/institutional-holders/iovance-biotherapeutics-inc-462260100) | COM | 5,296,209 | $22 million | -1,053,354 |
| [Ultragenyx Pharmaceutical in](https://specstream.ai/data/institutional-holders/ultragenyx-pharmaceutical-in-90400d108) | COM | 596,495 | $19.9 million | No change |
| [Novocure LTD](https://specstream.ai/data/institutional-holders/novocure-ltd-g6674u108) | ORD SHS | 1,280,439 | $19.4 million | No change |
| [Syndax Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/syndax-pharmaceuticals-inc-87164f105) | COM | 864,986 | $18.9 million | No change |
| [Annexon Inc](https://specstream.ai/data/institutional-holders/annexon-inc-03589w102) | COM | 2,948,090 | $16.8 million | No change |
| [Bicara Therapeutics Inc](https://specstream.ai/data/institutional-holders/bicara-therapeutics-inc-055477103) | COM | 550,408 | $16.3 million | No change |
| [Caredx Inc](https://specstream.ai/data/institutional-holders/caredx-inc-14167l103) | COM | 531,870 | $15.2 million | No change |
| [Celldex Therapeutics Inc New](https://specstream.ai/data/institutional-holders/celldex-therapeutics-inc-new-15117b202) | COM NEW | 399,856 | $14.9 million | +103,448 |
| [Compass Therapeutics Inc](https://specstream.ai/data/institutional-holders/compass-therapeutics-inc-20454b104) | COM | 5,831,813 | $12.8 million | +4,317,309 |
| [Alkermes PLC](https://specstream.ai/data/institutional-holders/alkermes-plc-g01767105) | SHS | 242,560 | $12.7 million | No change |
| [First Tracks Biotherapeutics](https://specstream.ai/data/institutional-holders/first-tracks-biotherapeutics-337185102) | ORD SHS | 603,489 | $12.1 million | New |
| [Prothena Corp PLC](https://specstream.ai/data/institutional-holders/prothena-corp-plc-g72800108) | SHS | 1,143,155 | $11.2 million | -65,413 |
| [Travere Therapeutics Inc](https://specstream.ai/data/institutional-holders/travere-therapeutics-inc-89422g107) | COM | 167,525 | $9.5 million | -62,928 |
| [Taysha Gene Therapies Inc](https://specstream.ai/data/institutional-holders/taysha-gene-therapies-inc-877619106) | COM SHS | 1,391,382 | $9.5 million | No change |
| [Aclaris Therapeutics Inc](https://specstream.ai/data/institutional-holders/aclaris-therapeutics-inc-00461u105) | COM | 1,613,430 | $8.5 million | No change |

## New positions in Q2 2026

3 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [First Tracks Biotherapeutics](https://specstream.ai/data/institutional-holders/first-tracks-biotherapeutics-337185102) | ORD SHS | 603,489 | $12.1 million |
| [Sagimet Biosciences Inc](https://specstream.ai/data/institutional-holders/sagimet-biosciences-inc-786700104) | COM SER A | 250,000 | $1.9 million |
| [Newamsterdam Pharma Company](https://specstream.ai/data/institutional-holders/newamsterdam-pharma-company-n62509109) | ORDINARY SHARES | 44,359 | $1.5 million |

## Positions exited in Q2 2026

2 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| Amicus Therapeutic | COM | 1,113,045 | $16.1 million |
| [Denali Therapeutics Inc](https://specstream.ai/data/institutional-holders/denali-therapeutics-inc-24823r105) | COM | 234,582 | $4.5 million |

## Also on SpecStream

- [Palo Alto Investors LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1306923/000207367926000102/0002073679-26-000102-index.htm)
- [Palo Alto Investors LP investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/palo-alto-investors-lp-109171)
- [Largest 13F filers in California](https://specstream.ai/data/institutional-holdings/state/california)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Palo Alto, California

- [Doctors' offices in Palo Alto, California](https://specstream.ai/data/businesses/doctors-offices/palo-alto-california-united-states)
- [Dental clinics in Palo Alto, California](https://specstream.ai/data/businesses/dental-clinics/palo-alto-california-united-states)
- [Coffee shops in Palo Alto, California](https://specstream.ai/data/businesses/coffee-shops/palo-alto-california-united-states)
- [Business consulting firms in Palo Alto, California](https://specstream.ai/data/businesses/business-consulting-firms/palo-alto-california-united-states)
- [Biotechnology companies in Palo Alto, California](https://specstream.ai/data/businesses/biotechnology-companies/palo-alto-california-united-states)
- [Banks and credit unions in Palo Alto, California](https://specstream.ai/data/businesses/banks-and-credit-unions/palo-alto-california-united-states)
